CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Forest Laboratories Inc. v. Glenmark Generics Inc. USA

1:14-cv-00159

Overview

Case Number 1:14-cv-00159
Filing Date 2014-02-06
Status Terminated
Termination Date 2015-12-21
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Glenmark Pharmaceuticals Ltd. Operating Company

Represented By

4 Attorneys Listed

Richard William Riley

Whiteford, Taylor & Preston LLC

Tel: +1 (302) 357-3255
Fax: +1 (302) 357-3275

Whiteford, Taylor & Preston LLC, 600 N. King Street

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Oderah C. Nwaeze

Faegre Drinker Biddle & Reath LLP

Tel: +1 (215) 988-1172
Fax: +1 (215) 988-2757

One Logan Square, Suite 2000

Gary William Lipkin

Eckert Seamans Cherin & Mellott, LLC

Tel: +1 (302) 574-7405

Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor

Glenmark Generics Ltd. Operating Company

Represented By

4 Attorneys Listed

Richard William Riley

Whiteford, Taylor & Preston LLC

Tel: +1 (302) 357-3255
Fax: +1 (302) 357-3275

Whiteford, Taylor & Preston LLC, 600 N. King Street

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Oderah C. Nwaeze

Faegre Drinker Biddle & Reath LLP

Tel: +1 (215) 988-1172
Fax: +1 (215) 988-2757

One Logan Square, Suite 2000

Gary William Lipkin

Eckert Seamans Cherin & Mellott, LLC

Tel: +1 (302) 574-7405

Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor

Glenmark Generics Inc. USA Operating Company

Represented By

6 Attorneys Listed

Patrick C. Gallagher Ph.D.

Email: pcgallagher@duanemorris.com

Kevin M. Nelson

Email: kevin.nelson@afslaw.com

Richard William Riley

Whiteford, Taylor & Preston LLC

Tel: +1 (302) 357-3255
Fax: +1 (302) 357-3275

Whiteford, Taylor & Preston LLC, 600 N. King Street

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Oderah C. Nwaeze

Faegre Drinker Biddle & Reath LLP

Tel: +1 (215) 988-1172
Fax: +1 (215) 988-2757

One Logan Square, Suite 2000

Gary William Lipkin

Eckert Seamans Cherin & Mellott, LLC

Tel: +1 (302) 574-7405

Eckert Seamans Cherin & Mellott, LLC, 222 Delaware Avenue, 7th Floor

Plaintiff

Royalty Pharma Collection Trust Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Forest Laboratories Holdings Ltd. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Forest Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6602911
Methods of treating fibromyalgia
Filed: 2001-12-19
Issued: 2003-08-05
Expired (Term Ended) +391d PTA
Expires: 2023-01-14
US7888342
Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain
Filed: 2009-12-22
Issued: 2011-02-15
Active (3.1 yrs remaining)
Expires: 2029-12-22
US7994220
Milnacipran for the long-term treatment of fibromyalgia syndrome
Filed: 2006-09-26
Issued: 2011-08-09
Active (2.8 yrs remaining) +1089d PTA
Expires: 2029-09-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+391 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Claim Construction / Markman Filing 1 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re 20 Joint STIPULATION TO EXTEND TIME to Defendants to Produce Core Technical Documents to May 9, 2014 filed by Glenmark Pharmaceuticals Ltd., Glen...
Entry #— • 2014-05-08
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME to Defendants to Produce Core Technical Documents to May 9, 2014 - filed by Glenmark Generics Inc. USA, Glenmark Generics Ltd.,...
Entry #20 • 2014-05-06 Document →
Claim Construction / Markman Filing Pending
SO ORDERED, re (27 in 1:13-cv-01603-SLR, 25 in 1:13-cv-01737-SLR, 21 in 1:13-cv-01606-SLR, 21 in 1:13-cv-01604-SLR, 19 in 1:14-cv-00159-SLR, 30 in 1:13-cv-01605...
Entry #— • 2014-03-20

Docket Entries

(37 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Glenmark Generics Inc. USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1456748.) - filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd., Royalty Pharma Collection Trust. (Attachments: # 1 Exhibit A - E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 02/07/2014)

Entry #1 • 2014-02-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 02/07/2014)

Entry #2 • 2014-02-06
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: on or about 1/03/2014. Date of Expiration of Patent: 6,602,911-01/14/2023;7,888,342-11/5/2021;7,994,220-09/19/2029.Thirty Month Stay Deadline: 7/14/2016. (dmp, ) (Entered: 02/07/2014)

Entry #3 • 2014-02-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,602,911 B2; 7,888,342 B2; 7,994,220 B2;. (dmp, ) (Entered: 02/07/2014)

Entry #4 • 2014-02-06
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent FL Holding CV for Forest Laboratories Holdings Ltd.; Other Affiliate FLI International LLC for Forest Laboratories Inc. filed by Forest Laboratories Holdings Ltd., Forest Laboratories Inc., Royalty Pharma Collection Trust. (dmp, ) (Entered: 02/07/2014)

Entry #5 • 2014-02-06
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc